Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (1444)	11/17/1998 11:18:00 AM
From: M. Ramle	Read Replies (1) \| Respond to of 10280

Vector1: All you have to do to analyze this "no-brainer" analyst is to look at his past record regarding SEPR as well as other stocks. A couple of weeks ago, he took SEPR down to a "Market Performer" (which in essence is a "Sell") at the $60 range for no valid reason except short-term valuation, only to see this stock rocket to $79 1/4. He has also been trying to push AZA for several quarters now, and his performance has been "duh". I remember his comments when he downgraded SEPR to a "Market Performer": << It really broke my heart to have to issue such a downgrade on this company>>. This guy should be a COMEDIAN instead. History always repeats itself in one form or another: SEPR performance has delivered thus far, and will continue to do so more effectively and efficiently than most other companies. Like David Southwell said yesterday during his interview on CNBC: "It is only the beginning of SEPR's potential success". Good Luck. Mazen